Novocure (NVCR) Misses Q4 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Paradium AI (PAAI) Halted, News Pending
- Shipping stocks on fire — but cracks are forming in the rate rally
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
NovoCure Ltd. (NVCR) PT Raised to $28 at Mizuho Securities Citing Potential for CMS Reimbursement Approval
February 23, 2018 4:44 AM ESTMizuho Securities raised its price target on NovoCure Ltd. (NASDAQ: NVCR) to $28.00 (from $25.00) while maintaining a Buy rating.
... More